Cargando…

The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis

BACKGROUND: Fifteen percent of patients with endometrial cancer (EC) have advanced stage disease or develop a recurrence. Progestins have been applied as systemic treatment for decades, but there is limited evidence on response prediction with biomarkers and toxicity. OBJECTIVES: To review the respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Weelden, Willem Jan, Birkendahl, Philine B., Lalisang, Roy I., IntHout, Joanna, Kruitwagen, Roy F. P. M., Romano, Andrea, Pijnenborg, Johanna M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100186/ https://www.ncbi.nlm.nih.gov/pubmed/36264251 http://dx.doi.org/10.1111/1471-0528.17331

Ejemplares similares

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Risk factors for pelvic organ prolapse and its recurrence: a systematic review
por: Vergeldt, Tineke F. M., et al.
Publicado: (2015)

Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study
por: van Lent, Marlies, et al.
Publicado: (2015)

The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis
por: Burg, Lara C., et al.
Publicado: (2022)

Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial
por: Milani, Alfredo L., et al.
Publicado: (2017)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
por: IntHout, Joanna, et al.
Publicado: (2014)

Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
por: Kluivers, Kirsten B., et al.
Publicado: (2023)

The impact of adipose tissue distribution on endometrial cancer: a systematic review
por: van den Bosch, Anouk A. S., et al.
Publicado: (2023)

The relative risk of noncervical high‐risk human papillomavirus‐related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population‐based study
por: Loopik, Diede L., et al.
Publicado: (2019)

Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
por: van Weelden, Geert, et al.
Publicado: (2019)

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
por: van de Laar, Rafli, et al.
Publicado: (2014)

Meta-Analyses of Animal Studies: An Introduction of a Valuable Instrument to Further Improve Healthcare
por: Hooijmans, Carlijn R., et al.
Publicado: (2014)

Gene Promoter Methylation in Endometrial Carcinogenesis
por: Cornel, Karlijn M. C., et al.
Publicado: (2018)

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
por: Kulkarni, A., et al.
Publicado: (2023)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
por: duPont, Nefertiti Chianti, et al.
Publicado: (2010)

A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence
por: Makai, Peter, et al.
Publicado: (2017)

Plea for routinely presenting prediction intervals in meta-analysis
por: IntHout, Joanna, et al.
Publicado: (2016)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Impact of a nutritional supplement (Impryl) on male fertility: study protocol of a multicentre, randomised, double-blind, placebo-controlled clinical trial (SUppleMent Male fERtility, SUMMER trial)
por: Smits, Roos, et al.
Publicado: (2020)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker
por: Dandis, Rana, et al.
Publicado: (2019)

Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study
por: Belias, Michail, et al.
Publicado: (2019)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Predicting personalised absolute treatment effects in individual participant data meta‐analysis: An introduction to splines
por: Belias, Michail, et al.
Publicado: (2022)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
por: Vrede, Stephanie W., et al.
Publicado: (2022)

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
por: Houshdaran, Sahar, et al.
Publicado: (2020)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Tissue Engineering in Animal Models for Urinary Diversion: A Systematic Review
por: Sloff, Marije, et al.
Publicado: (2014)

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021)

Intracerebral microdialysis of adenosine and adenosine monophosphate – a systematic review and meta‐regression analysis of baseline concentrations
por: van der Mierden, Stevie, et al.
Publicado: (2018)

Multimodal Balance Training Supported by Rhythmical Auditory Stimuli in Parkinson’s Disease: A Randomized Clinical Trial
por: Capato, Tamine T.C., et al.
Publicado: (2020)

Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature
por: Restaino, Stefano, et al.
Publicado: (2022)

Oestrogen receptor pathway activity is associated with outcome in endometrial cancer
por: van Weelden, Willem Jan, et al.
Publicado: (2020)

Effects of a Personal Health Record in Maternity Care: A Stepped-Wedge Trial
por: Groenen, Carola J. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m44a9pfusduf4c8ebtp0cepfrp